Our **** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Organic revenue growth of 13.7% was driven by strong underlying market demand and execution across the 'Big 3' businesses: CRM, CST, and Surgical.
Cardiac Ablation Solutions (CAS) delivered 88% growth, fueled by Sphere-9 share gains and the Affera mapping platform reaching a $2 billion trailing 12-month revenue milestone.
The AiBLE ecosystem in Cranial & Spinal Technologies is driving growth by connecting AI-driven planning, robotics, and navigation, which traditionally operated in silos.
Management attributes the broad-based performance to the compounding impact of multi-year strategic, operational, and cultural changes aimed at commercial consistency.
#Growth #driven #solutions
Organic revenue growth of 13.7% was driven by strong underlying market demand and execution across the 'Big 3' businesses: CRM, CST, and Surgical.
Cardiac Ablation Solutions (CAS) delivered 88% growth, fueled by Sphere-9 share gains and the Affera mapping platform reaching a $2 billion trailing 12-month revenue milestone.
The AiBLE ecosystem in Cranial & Spinal Technologies is driving growth by connecting AI-driven planning, robotics, and navigation, which traditionally operated in silos.
Management attributes the broad-based performance to the compounding impact of multi-year strategic, operational, and cultural changes aimed at commercial consistency.
#Growth #driven #solutions
14 days ago
